$6.63 Billion is the total value of RTW INVESTMENTS, LP's 113 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 25.2% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
RCKT | Sell | ROCKET PHARMACEUTICALS INC | $663,920,000 | -4.8% | 14,990,286 | -4.6% | 10.02% | -8.0% |
SPY | Buy | SPDR S&P 500 ETF TRtr unit | $426,457,000 | +13.7% | 996,255 | +5.3% | 6.44% | +9.9% |
ALNY | ALNYLAM PHARMACEUTICALS INC | $285,364,000 | +20.1% | 1,683,362 | 0.0% | 4.31% | +16.1% | |
DRNA | Buy | DICERNA PHARMACEUTICALS INC | $280,716,000 | +47.1% | 7,521,859 | +0.8% | 4.24% | +42.2% |
VCEL | VERICEL CORP | $237,172,000 | -5.5% | 4,517,570 | 0.0% | 3.58% | -8.7% | |
MRTX | Buy | MIRATI THERAPEUTICS INC | $235,435,000 | +3.1% | 1,457,532 | +9.3% | 3.55% | -0.3% |
ILMN | Buy | ILLUMINA INC | $228,462,000 | +23.4% | 482,791 | +0.2% | 3.45% | +19.3% |
PTCT | PTC THERAPEUTICS INC | $223,776,000 | -10.7% | 5,293,966 | 0.0% | 3.38% | -13.7% | |
ESTA | ESTABLISHMENT LABS HLDGS INC | $202,554,000 | +39.7% | 2,319,138 | 0.0% | 3.06% | +35.0% | |
MASI | Buy | MASIMO CORP | $200,315,000 | +46.6% | 826,210 | +38.9% | 3.02% | +41.7% |
NTRA | NATERA INC | $194,390,000 | +11.8% | 1,712,234 | 0.0% | 2.93% | +8.1% | |
PTGX | PROTAGONIST THERAPEUTICS INC | $157,412,000 | +73.3% | 3,507,390 | 0.0% | 2.38% | +67.5% | |
TXG | Buy | 10X GENOMICS INC | $143,826,000 | +11.7% | 734,481 | +3.2% | 2.17% | +8.0% |
CLDX | CELLDEX THERAPEUTICS INC NEW | $130,715,000 | +62.3% | 3,908,947 | 0.0% | 1.97% | +56.9% | |
DERMTECH INC | $129,643,000 | -18.2% | 3,118,665 | 0.0% | 1.96% | -20.9% | ||
GMED | GLOBUS MED INCcl a | $129,538,000 | +25.7% | 1,670,811 | 0.0% | 1.96% | +21.5% | |
AXNX | Buy | AXONICS INC | $123,260,000 | +9.2% | 1,943,864 | +3.2% | 1.86% | +5.6% |
STOK | STOKE THERAPEUTICS INC | $122,665,000 | -13.3% | 3,644,248 | 0.0% | 1.85% | -16.2% | |
GH | Buy | GUARDANT HEALTH INC | $114,038,000 | +22.5% | 918,253 | +50.6% | 1.72% | +18.4% |
QDEL | QUIDEL CORP | $112,558,000 | +0.1% | 878,533 | 0.0% | 1.70% | -3.2% | |
TNDM | Buy | TANDEM DIABETES CARE INC | $111,758,000 | +11.2% | 1,147,408 | +0.7% | 1.69% | +7.5% |
AXSM | AXSOME THERAPEUTICS INC | $109,049,000 | +19.1% | 1,616,497 | 0.0% | 1.65% | +15.2% | |
RNA | AVIDITY BIOSCIENCES INC | $98,716,000 | +13.3% | 3,995,000 | 0.0% | 1.49% | +9.6% | |
EPIX | Buy | ESSA PHARMA INC | $87,250,000 | +958.7% | 3,053,919 | +976.5% | 1.32% | +920.9% |
CCCC | C4 THERAPEUTICS INC | $81,327,000 | +2.4% | 2,149,228 | 0.0% | 1.23% | -1.0% | |
RXDX | PROMETHEUS BIOSCIENCES INC | $75,989,000 | +46.9% | 3,264,031 | 0.0% | 1.15% | +42.0% | |
IDYA | Buy | IDEAYA BIOSCIENCES INC | $68,559,000 | +18.3% | 3,266,255 | +32.4% | 1.04% | +14.4% |
MGNX | Buy | MACROGENICS INC | $68,410,000 | +6.6% | 2,546,925 | +26.4% | 1.03% | +3.0% |
RGNX | Buy | REGENXBIO INC | $68,288,000 | +380.6% | 1,757,743 | +321.9% | 1.03% | +364.0% |
AGEN | Sell | AGENUS INC | $62,790,000 | +67.6% | 11,437,238 | -17.0% | 0.95% | +61.9% |
CSTL | CASTLE BIOSCIENCES INC | $58,591,000 | +7.1% | 799,009 | 0.0% | 0.88% | +3.5% | |
TARS | Sell | TARSUS PHARMACEUTICALS INC | $58,354,000 | -26.2% | 2,013,601 | -18.3% | 0.88% | -28.7% |
NSTG | NANOSTRING TECHNOLOGIES INC | $52,093,000 | -1.4% | 804,029 | 0.0% | 0.79% | -4.7% | |
LUNG | PULMONX CORP | $49,838,000 | -3.5% | 1,129,600 | 0.0% | 0.75% | -6.8% | |
RLMD | Buy | RELMADA THERAPEUTICS INC | $49,232,000 | -8.7% | 1,538,026 | +0.5% | 0.74% | -11.7% |
LABP | LANDOS BIOPHARMA INC | $48,457,000 | +26.4% | 4,275,722 | 0.0% | 0.73% | +22.2% | |
IMCR | IMMUNOCORE HLDGS PLCads | $47,888,000 | -4.5% | 1,245,532 | 0.0% | 0.72% | -7.7% | |
ITOS | Sell | ITEOS THERAPEUTICS INC | $44,030,000 | -53.4% | 1,716,585 | -37.9% | 0.66% | -55.0% |
PRQR | Buy | PROQR THRAPEUTICS N V | $43,427,000 | +2.3% | 6,443,113 | +0.3% | 0.66% | -1.2% |
OLK | Buy | OLINK HLDG ABsponsored ads | $42,963,000 | +542.2% | 1,248,188 | +571.7% | 0.65% | +523.1% |
GHRS | New | GH RESEARCH PLCordinary shares | $42,661,000 | – | 2,168,957 | +100.0% | 0.64% | – |
ISEE | IVERIC BIO INC | $42,420,000 | +2.1% | 6,722,624 | 0.0% | 0.64% | -1.4% | |
CYTK | CYTOKINETICS INC | $39,580,000 | -14.9% | 2,000,000 | 0.0% | 0.60% | -17.8% | |
AVDL | AVADEL PHARMACEUTICALS PLCsponsored adr | $38,643,000 | -25.6% | 5,741,939 | 0.0% | 0.58% | -28.0% | |
OM | Buy | OUTSET MED INC | $36,843,000 | -1.4% | 737,152 | +7.3% | 0.56% | -4.6% |
GTH | GENETRON HLDGS LTDads | $36,618,000 | -6.2% | 1,818,162 | 0.0% | 0.55% | -9.2% | |
CUTR | New | CUTERA INC | $35,342,000 | – | 720,817 | +100.0% | 0.53% | – |
APYX | APYX MEDICAL CORPORATION | $34,964,000 | +6.7% | 3,391,279 | 0.0% | 0.53% | +3.3% | |
MDXG | MIMEDX GROUP INC | $33,781,000 | +21.5% | 2,700,320 | 0.0% | 0.51% | +17.5% | |
FULC | FULCRUM THERAPEUTICS INC | $33,591,000 | -11.0% | 3,205,291 | 0.0% | 0.51% | -13.9% | |
OYST | OYSTER PT PHARMA INC | $31,994,000 | -6.0% | 1,861,209 | 0.0% | 0.48% | -9.0% | |
JNJ | JOHNSON & JOHNSON | $28,095,000 | +0.2% | 170,542 | 0.0% | 0.42% | -3.2% | |
ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $25,753,000 | -64.5% | 7,357,917 | +0.1% | 0.39% | -65.6% |
GLUE | New | MONTE ROSA THERAPEUTICS INC | $25,228,000 | – | 1,214,572 | +100.0% | 0.38% | – |
MIST | MILESTONE PHARMACEUTICALS IN | $23,733,000 | -5.0% | 4,315,102 | 0.0% | 0.36% | -8.2% | |
TELA | Buy | TELA BIO INC | $22,432,000 | +8.9% | 1,392,434 | +0.7% | 0.34% | +5.0% |
CLSD | CLEARSIDE BIOMEDICAL INC | $20,487,000 | +97.2% | 4,206,765 | 0.0% | 0.31% | +90.7% | |
TRILLIUM THERAPEUTICS INC | $20,286,000 | -9.7% | 2,091,389 | 0.0% | 0.31% | -12.8% | ||
ATHA | Sell | ATHIRA PHARMA INC | $19,523,000 | -60.0% | 1,906,557 | -28.1% | 0.30% | -61.3% |
ABUS | ARBUTUS BIOPHARMA CORP | $18,114,000 | -9.0% | 5,978,355 | 0.0% | 0.27% | -12.2% | |
PMVP | PMV PHARMACEUTICALS INC | $16,538,000 | +3.9% | 484,133 | 0.0% | 0.25% | +0.4% | |
BWAY | BRAINSWAY LTDsponsored ads | $16,342,000 | +13.0% | 1,602,181 | 0.0% | 0.25% | +9.3% | |
BLU | BELLUS HEALTH INC NEW | $15,441,000 | -18.9% | 4,968,017 | 0.0% | 0.23% | -21.5% | |
NEO | New | NEOGENOMICS INC | $13,139,000 | – | 311,111 | +100.0% | 0.20% | – |
CERE | CEREVEL THERAPEUTICS HLDNG I | $12,810,000 | +86.6% | 500,000 | 0.0% | 0.19% | +80.4% | |
XGN | Sell | EXAGEN INC | $12,313,000 | -56.7% | 821,414 | -49.5% | 0.19% | -58.1% |
BMEA | New | BIOMEA FUSION INC | $12,270,000 | – | 830,794 | +100.0% | 0.18% | – |
INMD | INMODE LTD | $11,835,000 | +30.8% | 124,999 | 0.0% | 0.18% | +27.0% | |
BLI | BERKELEY LTS INC | $11,541,000 | -10.8% | 257,546 | 0.0% | 0.17% | -13.9% | |
IMUX | IMMUNIC INC | $11,289,000 | -23.1% | 920,814 | 0.0% | 0.17% | -25.8% | |
ASLN | ASLAN PHARMACEUTICALS LTDads | $10,725,000 | -1.5% | 3,250,000 | 0.0% | 0.16% | -4.7% | |
NAUT | New | NAUTILUS BIOTECHNOLOGY INC | $10,383,000 | – | 1,100,000 | +100.0% | 0.16% | – |
LJPC | LA JOLLA PHARMACEUTICAL CO | $9,963,000 | +0.9% | 2,327,903 | 0.0% | 0.15% | -2.6% | |
VINC | Buy | VINCERX PHARMA INC | $9,742,000 | +1.0% | 749,999 | +50.0% | 0.15% | -2.6% |
LSAQ | Buy | LIFESCI ACQUISITION II CORP | $9,750,000 | +47.9% | 975,000 | +50.0% | 0.15% | +42.7% |
ARGX | ARGENX SEsponsored adr | $9,560,000 | +9.3% | 31,752 | 0.0% | 0.14% | +5.1% | |
CTMX | Sell | CYTOMX THERAPEUTICS INC | $8,868,000 | -25.2% | 1,400,939 | -8.7% | 0.13% | -27.6% |
CNTB | CONNECT BIOPHARMA HLDGS LTDads | $8,789,000 | +5.6% | 450,000 | 0.0% | 0.13% | +2.3% | |
CHAQ | CHARDAN HEALTHCR ACQSTN 2 CO | $8,299,000 | -1.4% | 837,540 | 0.0% | 0.12% | -4.6% | |
HLXA | HELIX ACQUISITION CORP | $7,763,000 | +1.4% | 750,000 | 0.0% | 0.12% | -2.5% | |
AFIB | ACUTUS MED INC | $7,672,000 | +27.0% | 451,834 | 0.0% | 0.12% | +23.4% | |
BCTG | BCTG ACQUISITION CORP | $6,828,000 | +2.3% | 600,000 | 0.0% | 0.10% | -1.0% | |
RACB | RESEARCH ALLIANCE CORP II | $6,459,000 | -1.1% | 637,000 | 0.0% | 0.10% | -4.9% | |
BLSA | BCLS ACQUISITION CORP | $6,450,000 | -0.4% | 612,500 | 0.0% | 0.10% | -4.0% | |
ITMR | ITAMAR MED LTDsponsored ads | $6,326,000 | -1.7% | 268,609 | 0.0% | 0.10% | -5.0% | |
APVO | APTEVO THERAPEUTICS INC | $6,312,000 | -26.5% | 281,402 | 0.0% | 0.10% | -29.1% | |
RCEL | AVITA MEDICAL INC | $5,746,000 | +3.5% | 280,000 | 0.0% | 0.09% | 0.0% | |
ARYD | ARYA SCIENCES ACQU CORP IVcl a | $5,360,000 | +2.4% | 500,000 | 0.0% | 0.08% | -1.2% | |
SMIHU | New | SUMMIT HEALTHCRE ACQUISTN COunit 06/03/2026 | $5,005,000 | – | 500,000 | +100.0% | 0.08% | – |
RACA | THERAPEUTICS ACQUISITION COR | $5,034,000 | -2.3% | 490,000 | 0.0% | 0.08% | -5.0% | |
SRRK | SCHOLAR ROCK HLDG CORP | $4,671,000 | -42.9% | 161,612 | 0.0% | 0.07% | -45.3% | |
DNAY | New | CODEX DNA INC | $4,400,000 | – | 200,000 | +100.0% | 0.07% | – |
CVRX | New | CVRX INC | $4,200,000 | – | 150,000 | +100.0% | 0.06% | – |
IMTX | IMMATICS N.V | $4,064,000 | +3.6% | 350,000 | 0.0% | 0.06% | 0.0% | |
FVAM | 5 01 ACQUISITION CORP | $3,908,000 | +0.2% | 392,000 | 0.0% | 0.06% | -3.3% | |
CHAQU | CHARDAN HEALTHCR ACQSTN 2 COunit 99/99/9999 | $3,644,000 | -1.0% | 350,000 | 0.0% | 0.06% | -3.5% | |
MIRO | New | MIROMATRIX MED INC | $3,262,000 | – | 280,000 | +100.0% | 0.05% | – |
PSNL | PERSONALIS INC | $3,226,000 | +2.8% | 127,501 | 0.0% | 0.05% | 0.0% | |
MRVI | MARAVAI LIFESCIENCES HLDGS I | $2,921,000 | +17.1% | 70,000 | 0.0% | 0.04% | +12.8% | |
MSAC | New | MEDICUS SCIENCES ACQUISITION | $2,895,000 | – | 300,000 | +100.0% | 0.04% | – |
ZY | New | ZYMERGEN INC | $2,801,000 | – | 70,000 | +100.0% | 0.04% | – |
OMIC | New | SINGULAR GENOMICS SYSTEMS IN | $2,748,000 | – | 100,000 | +100.0% | 0.04% | – |
TWST | TWIST BIOSCIENCE CORP | $2,462,000 | +7.6% | 18,473 | 0.0% | 0.04% | +2.8% | |
CEREW | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $2,398,000 | +234.0% | 166,666 | 0.0% | 0.04% | +227.3% | |
PROF | PROFOUND MED CORP | $1,998,000 | -18.7% | 122,098 | 0.0% | 0.03% | -21.1% | |
BOLT | Sell | BOLT BIOTHERAPEUTICS INC | $1,954,000 | -60.4% | 126,365 | -15.8% | 0.03% | -62.3% |
AKYA | New | AKOYA BIOSCIENCES INC | $1,934,000 | – | 100,000 | +100.0% | 0.03% | – |
BDSX | BIODESIX INC | $1,651,000 | -35.0% | 125,000 | 0.0% | 0.02% | -37.5% | |
MASS | 908 DEVICES INC | $1,550,000 | -20.1% | 40,000 | 0.0% | 0.02% | -23.3% | |
AZYO | AZIYO BIOLOGICS INC | $1,201,000 | -30.5% | 125,000 | 0.0% | 0.02% | -33.3% | |
BNR | BURNING ROCK BIOTECH LTDsponsored ads | $884,000 | +9.4% | 30,000 | 0.0% | 0.01% | 0.0% | |
PROG | PROGENITY INC | $357,000 | -25.0% | 100,000 | 0.0% | 0.01% | -28.6% | |
MSACW | New | MEDICUS SCIENCES ACQUISITION*w exp 02/12/202 | $34,000 | – | 33,331 | +100.0% | 0.00% | – |
SEER | Exit | Seer Inc | $0 | – | -4,000 | -100.0% | -0.00% | – |
NUVBWS | Exit | Nuvation Bio Inc*w exp 07/07/202 | $0 | – | -100,000 | -100.0% | -0.00% | – |
BCAB | Exit | Bioatla Inc | $0 | – | -10,000 | -100.0% | -0.01% | – |
VINCW | Exit | Vincerx Pharma Inc wts $11.5 Exp. 12/24/2025*w exp 12/24/202 | $0 | – | -500,000 | -100.0% | -0.03% | – |
MSACU | Exit | Medicus Sciences Acquisitionunit 99/99/9999 | $0 | – | -300,000 | -100.0% | -0.05% | – |
NUVB | Exit | Nuvation Bio Inc | $0 | – | -300,000 | -100.0% | -0.05% | – |
ARYA | Exit | Arya Sciences Acquisition Co | $0 | – | -500,000 | -100.0% | -0.11% | – |
KURA | Exit | Kura Oncology Inc | $0 | – | -1,081,912 | -100.0% | -0.48% | – |
CRIS | Exit | Curis Inc | $0 | – | -3,619,544 | -100.0% | -0.64% | – |
TBIO | Exit | Translate Bio Inc | $0 | – | -4,382,199 | -100.0% | -1.13% | – |
IMVT | Exit | Immunovant Inc | $0 | – | -6,356,743 | -100.0% | -1.59% | – |
ARVN | Exit | Arvinas Inc | $0 | – | -1,622,799 | -100.0% | -1.68% | – |
CERN | Exit | Cerner Corp | $0 | – | -1,774,485 | -100.0% | -1.99% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-13
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | 36 | Q3 2023 | 19.7% |
MASIMO CORP | 32 | Q3 2023 | 5.8% |
LA JOLLA PHARMACEUTICAL CO | 31 | Q2 2022 | 9.7% |
REGENXBIO INC | 30 | Q4 2022 | 10.8% |
AGENUS INC | 29 | Q2 2022 | 9.0% |
PTC THERAPEUTICS INC | 28 | Q3 2023 | 12.8% |
DICERNA PHARMACEUTICALS INC | 28 | Q3 2021 | 10.8% |
MIRATI THERAPEUTICS INC | 26 | Q3 2023 | 6.2% |
ARGENX SE | 26 | Q3 2023 | 5.3% |
VERICEL CORP | 24 | Q3 2023 | 3.9% |
View RTW INVESTMENTS, LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
ROCKET PHARMACEUTICALS, INC. | September 19, 2023 | 18,188,457 | - |
ALLURION TECHNOLOGIES, INC. | August 11, 2023 | 3,457,707 | 7.4% |
Orchestra BioMed Holdings, Inc. | May 05, 2023 | 5,620,645 | 15.7% |
Renovacor, Inc.Sold out | April 05, 2023 | 0 | - |
Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Aptevo Therapeutics Inc.Sold out | February 14, 2023 | 0 | 0.0% |
ASLAN Pharmaceuticals LtdSold out | February 14, 2023 | 0 | 0.0% |
Athira Pharma, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
BELLUS Health Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Clearside Biomedical, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
View RTW INVESTMENTS, LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13D/A | 2024-03-01 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View RTW INVESTMENTS, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.